Medication info
Clocure 75 mg (Clopidogrel Hydrogen Sulfate)

Clocure 75 mg (Clopidogrel Hydrogen Sulfate)

Prescription medicationTablet
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
I-Cure Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603497 · Approved 2016.06.15 · Insurance code 674401140

Summary

Main use
Acute coronary syndrome, improvement of atherosclerotic symptoms, prevention of blood clots in atrial fibrillation
Who uses it
Adults
Adult dosage
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the day this drug is initiated with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be co-administered with this drug once daily. 3. In patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be co-administered with this drug once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered regardless of food intake.

Ingredients

Manufacturer
I-Cure Co., Ltd.

Efficacy & effects

Acute coronary syndrome, improvement of atherosclerotic symptoms, prevention of blood clots in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular events
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. Additionally, it improves atherosclerotic symptoms associated with cardiovascular events such as death, myocardial infarction, stroke, or refractory ischemia in patients with acute coronary syndrome, including those with unstable angina or non-Q wave myocardial infarction, and those who have undergone or will undergo coronary intervention or coronary artery bypass surgery. Furthermore, in adult patients with atrial fibrillation who have vascular risk factors and for whom vitamin K antagonists are not suitable and the risk of bleeding is low, it helps reduce the risk of atherosclerotic thrombosis and thromboembolism, including stroke.

Dosage and Administration

Adult dosage

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the day this drug is initiated with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be co-administered with this drug once daily. 3. In patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be co-administered with this drug once daily. ○ Patients with renal impairment: Experience with treatment in patients with renal impairment is limited. ○ Patients with hepatic impairment: Experience with treatment in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered regardless of food intake.

Precautions

This medication is a drug that prevents platelet aggregation and therefore prevents blood clotting. The efficacy of this drug may be reduced in individuals with genetic deficiencies in a specific enzyme (CYP2C19) in the liver; in such cases, alternative treatment methods should be considered. Additionally, taking medications that activate certain enzymes may increase the concentration of this drug's active ingredient, potentially raising the risk of bleeding; therefore, concurrent use is not recommended. This drug should not be used in patients with specific allergic reactions, those with bleeding issues, patients with severe liver dysfunction, nursing women, and patients with genetic problems such as lactose intolerance. Patients at high risk of bleeding or those with bleeding disorders, patients with impaired liver or kidney function, recent stroke patients, patients with hypertension, elderly patients, and underweight patients should exercise special caution when using this drug. The risk of bleeding may increase when this drug is used with other anticoagulant medications; strict adherence to a physician's instructions is necessary when using these together. If bleeding does not stop or the bleeding site continues to enlarge during therapy, notify a physician immediately, and if surgery is planned, the drug should be discontinued 5-7 days prior to the procedure. It is important to periodically check for bleeding or blood abnormalities through blood tests during treatment with this drug. Women who are pregnant or nursing should consult a physician before taking this medication, as the risk of bleeding may increase during childbirth. This drug has not been established as safe or effective for use in children, so its use is not recommended. In the event of overdose, bleeding times may be prolonged and complications from bleeding may arise, so strict adherence to the recommended dosage is essential; if overdose is suspected, seek medical attention immediately. This medication should be stored out of reach of children, and transferring it to other containers can cause accidents, so care must be taken.

Side effects

Hemorrhage, gastrointestinal hemorrhage, hemorrhage requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, severe neutropenia, aplastic anemia, severe thrombocytopenia, gastrointestinal symptoms, abdominal pain, dyspepsia, diarrhea, rash, pruritus, depression, headache, dizziness, nausea, thrombocytopenia, anemia, pneumonia, sinusitis, cough, rash, itching, contact dermatitis, urinary tract infection, decreased motor function, tremor, speech impairment, abnormal gait, hyperkinesia, ataxia, sensory disturbance, insomnia, depression, forgetfulness, anxiety, somnolence, abnormal thought, abnormal behavior, arthralgia, myalgia, low back pain, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, purpura, hematochezia, hematoma, hematuria, hemoptysis, muscular hemorrhage, intracranial hemorrhage, ocular hemorrhage, gingival hemorrhage, thrombocytopenia, anemia, cough, dyspnea, rhinitis, visual disturbance, visual field impairment, dry eye syndrome, transient blindness, congestion, tinnitus, urinary difficulties, polyuria, non-protein nitrogen increase, uremia, blood urea nitrogen increase, hypoglycemia, hyperuricemia, increased liver enzymes, elevated ALT, abnormal liver function, leg edema, arrhythmia, bradycardia, palpitations, rash, itching, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, generalized edema, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforating gastric ulcer, upper gastrointestinal tract ulcer hemorrhage, distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, intracranial hemorrhage, retroperitoneal hemorrhage, surgical wound hemorrhage, ocular hemorrhage, pulmonary hemorrhage, purpura, thrombocytopenia, aplastic anemia, hypochromic anemia, agranulocytosis, granulocytopenia, leukemia, leukopenia, neutropenia, eosinophilia, menorrhagia, hemothorax, herpes simplex, erythema multiforme, papular rash, urticaria, renal function abnormalities, acute kidney failure, cholecystitis, hematemesis, spinal cord hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This product should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is advisable to store it at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.